Boffa DJ, et al. - In this retrospective-cohort, noninferiority study, researchers tested the hypothesis that the minimally invasive approach to lobectomy for stage I lung cancer resulted in a longitudinal outcome that was not inferior to thoracotomy. They analyzed patients > 65 years of age who had undergone lobectomy for stage I lung cancer between 2002 and 2013 within the Society of Thoracic Surgeons General Thoracic Surgery Database, which had been linked to Medicare data. Seemingly, no inferior long-term efficacy was provided by lobectomy for stage I lung cancer performed using the video-assisted thoracic surgery approach by board-certified thoracic surgeons when compared to thoracotomy.